Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022685407> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2022685407 endingPage "109" @default.
- W2022685407 startingPage "107" @default.
- W2022685407 abstract "To explore the different sequence interactions between reversible non-steroidal (anastrozole, ANZ and letrozole, LTZ) and non-reversible steroidal aromatase inhibitors (formestane, FOR and exemestane, EXE), we evaluated the clinical benefit (CB) in postmenopausal breast cancer patients, who had previously received anastrozole and subsequently formestane. In 19 out of 21 patients (90.5%), a clinical benefit response was achieved by anastrozole, with a median duration of 12 months. Out of the 21 women progressing on anastrozole, 12 achieved stable disease (SD)>/=6 months by formestane only. The overall clinical benefit was 66.5%. The median duration of clinical benefit was 11 months with a time to progression of 6.5 months. The median duration of clinical benefit in our series is similar to that reported in two phase II trials with the sequence aminogluthetimide-->formestane and aminogluthetimide-->exemestane as third-line hormonal therapy, suggesting a non-cross-resistance between the two classes of inhibitors." @default.
- W2022685407 created "2016-06-24" @default.
- W2022685407 creator A5001910485 @default.
- W2022685407 creator A5020732852 @default.
- W2022685407 creator A5045496715 @default.
- W2022685407 creator A5045603955 @default.
- W2022685407 creator A5052556729 @default.
- W2022685407 creator A5056071190 @default.
- W2022685407 creator A5057333100 @default.
- W2022685407 creator A5058082424 @default.
- W2022685407 creator A5061240925 @default.
- W2022685407 creator A5068497911 @default.
- W2022685407 creator A5072115818 @default.
- W2022685407 creator A5086199413 @default.
- W2022685407 date "2003-07-01" @default.
- W2022685407 modified "2023-10-12" @default.
- W2022685407 title "Is there a benefit by the sequence anastrozole–formestane for postmenopausal metastatic breast cancer women?" @default.
- W2022685407 cites W1848530042 @default.
- W2022685407 cites W1990603654 @default.
- W2022685407 cites W2003566890 @default.
- W2022685407 cites W2039483671 @default.
- W2022685407 cites W206058026 @default.
- W2022685407 cites W2077114772 @default.
- W2022685407 cites W2170587941 @default.
- W2022685407 cites W4230176650 @default.
- W2022685407 cites W4249367441 @default.
- W2022685407 doi "https://doi.org/10.1016/s0960-0760(03)00249-8" @default.
- W2022685407 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12943750" @default.
- W2022685407 hasPublicationYear "2003" @default.
- W2022685407 type Work @default.
- W2022685407 sameAs 2022685407 @default.
- W2022685407 citedByCount "11" @default.
- W2022685407 countsByYear W20226854072019 @default.
- W2022685407 countsByYear W20226854072020 @default.
- W2022685407 countsByYear W20226854072023 @default.
- W2022685407 crossrefType "journal-article" @default.
- W2022685407 hasAuthorship W2022685407A5001910485 @default.
- W2022685407 hasAuthorship W2022685407A5020732852 @default.
- W2022685407 hasAuthorship W2022685407A5045496715 @default.
- W2022685407 hasAuthorship W2022685407A5045603955 @default.
- W2022685407 hasAuthorship W2022685407A5052556729 @default.
- W2022685407 hasAuthorship W2022685407A5056071190 @default.
- W2022685407 hasAuthorship W2022685407A5057333100 @default.
- W2022685407 hasAuthorship W2022685407A5058082424 @default.
- W2022685407 hasAuthorship W2022685407A5061240925 @default.
- W2022685407 hasAuthorship W2022685407A5068497911 @default.
- W2022685407 hasAuthorship W2022685407A5072115818 @default.
- W2022685407 hasAuthorship W2022685407A5086199413 @default.
- W2022685407 hasConcept C121608353 @default.
- W2022685407 hasConcept C126322002 @default.
- W2022685407 hasConcept C143998085 @default.
- W2022685407 hasConcept C2775860665 @default.
- W2022685407 hasConcept C2775930923 @default.
- W2022685407 hasConcept C2776166826 @default.
- W2022685407 hasConcept C2776215463 @default.
- W2022685407 hasConcept C2778504769 @default.
- W2022685407 hasConcept C2778812593 @default.
- W2022685407 hasConcept C29456083 @default.
- W2022685407 hasConcept C530470458 @default.
- W2022685407 hasConcept C535046627 @default.
- W2022685407 hasConcept C71924100 @default.
- W2022685407 hasConceptScore W2022685407C121608353 @default.
- W2022685407 hasConceptScore W2022685407C126322002 @default.
- W2022685407 hasConceptScore W2022685407C143998085 @default.
- W2022685407 hasConceptScore W2022685407C2775860665 @default.
- W2022685407 hasConceptScore W2022685407C2775930923 @default.
- W2022685407 hasConceptScore W2022685407C2776166826 @default.
- W2022685407 hasConceptScore W2022685407C2776215463 @default.
- W2022685407 hasConceptScore W2022685407C2778504769 @default.
- W2022685407 hasConceptScore W2022685407C2778812593 @default.
- W2022685407 hasConceptScore W2022685407C29456083 @default.
- W2022685407 hasConceptScore W2022685407C530470458 @default.
- W2022685407 hasConceptScore W2022685407C535046627 @default.
- W2022685407 hasConceptScore W2022685407C71924100 @default.
- W2022685407 hasIssue "1" @default.
- W2022685407 hasLocation W20226854071 @default.
- W2022685407 hasLocation W20226854072 @default.
- W2022685407 hasOpenAccess W2022685407 @default.
- W2022685407 hasPrimaryLocation W20226854071 @default.
- W2022685407 hasRelatedWork W1577400276 @default.
- W2022685407 hasRelatedWork W1941904566 @default.
- W2022685407 hasRelatedWork W1972421336 @default.
- W2022685407 hasRelatedWork W1975279241 @default.
- W2022685407 hasRelatedWork W1978282985 @default.
- W2022685407 hasRelatedWork W1991981105 @default.
- W2022685407 hasRelatedWork W2046794494 @default.
- W2022685407 hasRelatedWork W2090744251 @default.
- W2022685407 hasRelatedWork W2408919041 @default.
- W2022685407 hasRelatedWork W2533016636 @default.
- W2022685407 hasVolume "86" @default.
- W2022685407 isParatext "false" @default.
- W2022685407 isRetracted "false" @default.
- W2022685407 magId "2022685407" @default.
- W2022685407 workType "article" @default.